154 related articles for article (PubMed ID: 20047861)
1. Current status and problems in development of molecular target agents for gastrointestinal malignancy in Japan.
Boku N
Jpn J Clin Oncol; 2010 Mar; 40(3):183-7. PubMed ID: 20047861
[TBL] [Abstract][Full Text] [Related]
2. [Globalization of clinical trials].
Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
[TBL] [Abstract][Full Text] [Related]
3. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
Ekimoto H
Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
[TBL] [Abstract][Full Text] [Related]
6. [Participation to international registration trials--from the investigator's standpoint].
Ohtsu A
Gan To Kagaku Ryoho; 2007 Feb; 34(2):297-300. PubMed ID: 17301548
[TBL] [Abstract][Full Text] [Related]
7. [The progress of second-line chemotherapy and molecular targeting agents in gastric cancer].
Takiuchi H
Gan To Kagaku Ryoho; 2009 May; 36(5):717-20. PubMed ID: 19461169
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
9. Successful gastrointestinal cancer drug development.
Hecht JR
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S24-7. PubMed ID: 17178281
[TBL] [Abstract][Full Text] [Related]
10. [Development of an anticancer drug in Japan based on a new clinical trial system].
Nakashima H; Nakano S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):287-94. PubMed ID: 9492818
[TBL] [Abstract][Full Text] [Related]
11. The latest advances in chemotherapy for gastrointestinal cancers.
Ohtsu A
Int J Clin Oncol; 2003 Aug; 8(4):234-8. PubMed ID: 12955579
[TBL] [Abstract][Full Text] [Related]
12. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
13. Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.
Hochster HS; Haller DG; de Gramont A; Berlin JD; Philip PA; Moore MJ; Ajani JA
Cancer; 2006 Aug; 107(4):676-85. PubMed ID: 16847885
[TBL] [Abstract][Full Text] [Related]
14. Strategy for the development of novel anticancer drugs.
Saijo N; Tamura T; Nishio K
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S97-101. PubMed ID: 12856152
[TBL] [Abstract][Full Text] [Related]
15. [Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development].
Akaza H; Aiba K; Isonishi S; Ogawa O; Shibuya M; Sone S; Tsuruo T; Noguchi S; Hinotsu S; Kono S; Mikami O; Blackledge G; Vose B; Stribling D
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1681-93. PubMed ID: 11057319
[TBL] [Abstract][Full Text] [Related]
16. [Tuberculosis and its control--lessons from the past and future prospect].
Shimao T
Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
[TBL] [Abstract][Full Text] [Related]
17. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
[TBL] [Abstract][Full Text] [Related]
18. [Impact of rapid advancement of international standardization on technical requirements for new drug registration].
Kurokawa T
Gan To Kagaku Ryoho; 1996 Apr; 23(5):509-16. PubMed ID: 8678507
[TBL] [Abstract][Full Text] [Related]
19. New, expanded, and modified use of approved antineoplastic agents in ovarian cancer.
Markman M
Oncologist; 2007 Feb; 12(2):186-90. PubMed ID: 17296814
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
